Consortium advancing cancer care for people with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535252 · Data updated 2026-11-12
A nationwide network tests new cancer treatments and prevention strategies to help people living with HIV reduce their cancer risk and improve outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $163,250 |
| NIH project number | 3UM1CA121947-20S4 |
| Project ID | NIH-11535252 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV who are at risk for or have cancer, and who can participate in cancer-related clinical trials within AMC-affiliated sites.
✕Less likely to help
Individuals without HIV or those not eligible for AMC cancer trials may not directly benefit.
What this research studies
The AIDS Malignancy Consortium runs clinical trials focused on cancers that affect people with HIV, aiming to find better treatments and prevention methods. It collaborates across 39 sites in the U.S. and other countries, engaging scientists, clinicians, and community advocates. The program has a history of generating practice-changing guidelines and building translational science collaborations to address HIV-associated cancers. It emphasizes involving people living with HIV and survivors in planning and outreach to ensure research meets real-world needs. This grant supports continued interventional studies and the expansion of a global research network.
Why it matters
Potential benefit: If successful, patients with HIV could receive more effective cancer therapies and better prevention options, improving survival and quality of life.
How similar studies have gone: AMC has a long track record of interventional trials, publications, and guideline impact, indicating successful translation of research into practice.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.